RecruitingNot ApplicableNCT05612789

Improve Outcomes for Older Allogeneic Transplant Recipients

Intervening on Frailty to Improve Outcomes for Older Allogeneic Transplant Recipients


Sponsor

Abramson Cancer Center at Penn Medicine

Enrollment

72 participants

Start Date

Feb 15, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

This is an interventional pilot study to determine whether implementation of a supervised exercise program can improve outcomes in subjects undergoing allogeneic HCT. The primary objective is to determine feasibility. Up to 60-72 evaluable subjects will be enrolled. Evaluable subjects are defined as those participating in the exercise intervention.


Eligibility

Min Age: 60 Years

Inclusion Criteria9

  • Cohort A (Prehab)
  • Age 60 years or older.
  • Planned allogeneic HCT in the next 1-6 months.
  • Hematological malignancy as the indication for HCT.
  • Pre-frail or frail by Fried frailty phenotype.
  • Cohort B (Rehab)
  • Age 60 years or older.
  • Planned allogeneic HCT or HCT within the last 30 days.
  • Hematological malignancy as the indication for HCT.

Exclusion Criteria2

  • Cohorts A and B
  • \. Comorbid disability or illness that prevents safe exercise.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALExercise Program (Cohort A Prehab)

Pre-frail and frail potential HCT recipients 60 years and older will participate in a supervised exercise program from the time of enrollment up until HCT admission. Exercise compliance will be measured in part through physical activity trackers.from time of discharge from HCT until day +100 post-HCT. All HCT recipients 60 years and older will participate in a supervised exercise program from the time of discharge from HCT admission until day +100 post-HCT. Exercise compliance will be measured in part through physical activity trackers.

BEHAVIORALExercise Program (Cohort B Rehab)

All HCT recipients 60 years and older will participate in a supervised exercise program from the time of discharge from HCT admission until day +100 post-HCT. Exercise compliance will be measured in part through physical activity trackers.


Locations(1)

Penn Medicine

Philadelphia, Pennsylvania, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05612789


Related Trials